Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2026 Earnings Call Transcript
Najat Khan: Good morning, everyone, and thank you for joining us.
Recursion Pharmaceuticals Inc. (RXRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hurley Capital Charles Goldblum | 850 | $2,610 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.82 | 66,822 | $522,354.26 | 12,985,927 | 2023-03-02 | Filing | |
| $7.94 | 48,867 | $388,082.17 | 12,919,105 | 2023-03-01 | Filing | |
| $7.97 | 815 | $6,495.55 | 12,870,238 | 2023-02-28 | Filing | |
| $7.69 | 52,500 | $403,725.00 | 12,869,423 | 2023-02-27 | Filing | |
| $7.64 | 109,118 | $833,552.40 | 12,816,923 | 2023-02-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.37 | 40,000 | $134,800.00 | 926,556 | 2026-05-07 | Filing | |
| $3.52 | 30,000 | $105,600.00 | 6,199,863 | 2026-05-05 | Filing | |
| $3.61 | 40,000 | $144,400.00 | 906,556 | 2026-04-22 | Filing | |
| $3.10 | 40,000 | $124,000.00 | 906,556 | 2026-04-07 | Filing | |
| $3.10 | 30,000 | $93,000.00 | 6,229,863 | 2026-04-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,675,407 | $72,683,499 | 0.07% | |
| 2. | 22,759,100 | $69,870,437 | 0% | |
| 3. | 22,244,387 | $68,290,268 | 0% | |
| 4. | 5,419,221 | $16,637,008 | 0.01% | |
| 5. | 5,419,221 | $16,582,816 | 0.23% |
News See All
12 Best AI Stocks Under $50 to Buy Right Now
On May 5, Joe Lonsdale, 8VC Founding Partner & Palantir Co-Founder, appeared on CNBC's 'Squawk Box' to discuss reports that the US government is considering reviewing AI tech before its public release...
8 Best Fundamentally Strong Penny Stocks to Invest In Now
Penny stocks are often associated with high risk and speculative trading, but not all penny stocks are the same.
10 Most Shorted Penny Stocks to Buy
In this article, we will take a look at some of the most shorted penny stocks that currently appear highly attractive with impressive upside potential.
9 Must-Buy Penny Stocks to Invest In Now
A potential breakthrough in the US/Israel-Iran conflict lit fire under Wall Street on April 17.
10 Best Medical AI Stocks to Buy Now
Artificial intelligence has driven significant gains in the equity market over the past two years.
10 Best Multibagger Penny Stocks to Invest In
Small-cap and penny stocks are often overlooked by Wall Street as they tend to be extremely volatile.
Jim Cramer Answered Questions About 13 Stocks: Eli Lilly, Meta, and More
A couple of weeks ago, Jack Dorsey, CEO of Block, the old Square, did the unthinkable, saying he would cut his workforce almost in half from 10,000 people to just 6,000.
What Makes Recursion Pharmaceuticals (RXRX) So Attractive
On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million compared to the consensus estimates of $24.6 million.
11 Most Popular AI Penny Stocks to Buy Now
The need for the adoption of Artificial Intelligence (AI) is becoming increasingly pivotal for businesses to elevate their operations.
Hedge Fund Resource Center